Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves Egrifta for lipodystrophy in HIV-infected patients

Nov. 12, 2010

Repros Therapeutics reports on type B meeting with FDA regarding Androxal

Nov. 12, 2010

Bionovo receives FDA approval for clinical development plan for Menerba

Nov. 12, 2010

Patient screening complete for phase III rhGAD65 trial in type 1 diabetes

Nov. 10, 2010

ECLIPSE trial compares Epanova with Lovaza

Nov. 10, 2010

In vivo data support potential of galantamine for treatment of obesity and related complications

Nov. 10, 2010

Results reported from phase III BLOOM-DM weight loss study in type 2 diabetes

Nov. 9, 2010

Ardea Biosciences reports data on RDEA-594 in gout

Nov. 9, 2010

Phase IIb data reported on LIPO-102 for selective nonablative fat reduction

Nov. 8, 2010

FDA approves once-daily Kombiglyze XR tablets for type 2 diabetes

Nov. 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...